Jong Joseph Kim - 26 Feb 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Executive Officer, Director
Signature: /s/ Jong Joseph Kim
Issuer symbol: INO
Transactions as of: 26 Feb 2022
Net transactions value: -$64,545
Form type: 4
Filing time: 01 Mar 2022, 17:38:58 UTC
Next filing: 09 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+68,767	+5.6%		1,297,425	26 Feb 2022	Direct	F1
transaction	INO	Common Stock	Tax liability	$64,545	-20,045	-1.5%	$3.22^*	1,277,380	26 Feb 2022	Direct	F2
holding	INO	Common Stock						816,527	26 Feb 2022	By Family Limited Partnership
holding	INO	Common Stock						33,563	26 Feb 2022	By Daughter: EK
holding	INO	Common Stock						33,775	26 Feb 2022	By Son: JK1
holding	INO	Common Stock						5,975	26 Feb 2022	By Spouse
holding	INO	Common Stock						33,533	26 Feb 2022	By Son: JK2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-68,767	-33%	$0.000000	137,533	26 Feb 2022	Common Stock	68,767		Direct	F1
transaction	INO	Common Stock Option	Award	$0	+627,700		$0.000000	627,700	26 Feb 2022	Common Stock	627,700	$3.22	Direct	F3
transaction	INO	Restricted Stock Unit	Award	$0	+468,500		$0.000000	468,500	26 Feb 2022	Common Stock	468,500		Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 206,300 restricted stock units is as follows: 68,767 shares vested on February 26, 2022; 68,767 shares will vest on February 26, 2023; 68,766 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
F3	The vesting schedule for the 627,700 options is as follows: 156,925 shares vested on February 26, 2022; 156,925 shares will vest on February 26, 2023; 156,925 shares will vest on February 26, 2024; 156,925 shares will vest on February 26, 2025.
F4	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 468,500 restricted stock units is as follows: 156,167 shares will vest on February 26, 2023; 156,167 shares will vest on February 26, 2024; 156,166 shares will vest on February 26, 2025. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.